Stay updated with breaking news from Yehuda Ringel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biomica to Present at Digestive Disease Week Conference 2024 Annual Meeting REHOVOT, Israel, April 11, 2024. Biomica Ltd., a...
/PRNewswire/ -- Biomica, a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd....
/PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd....
Share this article Share this article REHOVOT, Israel, Jan. 21, 2021 /PRNewswire/ -- Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), today announced it will be featured as a presenting company at the Crohn's & Colitis Congress® to be held from today January 21-24, 2021. Prof. Yehuda Ringel, CSO of Biomica, will present " BMC322 - A rationally-designed live bacterial consortium based on microbiome functional genomic analysis for treatment of IBD" on Saturday 23 rd Janua...